Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of HBM9378/WIN378 in patients with asthma, with an ...

Roche’s IgG2 monoclonal antibody (mAb) astegolimab has yielded mixed results in chronic obstructive pulmonary disease (COPD), ...

Over the past few weeks, the Valley has experienced heavy rain and flooding in the area. However, heavy rain can harm not ...

Joan B Soriano had no particular aspiration to become a doctor, and no one in his family studied Medicine. But growing up in ...

A recent Veterans Health Administration (VHA) study published in the Journal of American Medical Association revealed that ...

“When they go in and out, back and forth, the temperature shifts cause some problems as well, and then that adds to the ...

Veterans Affairs data-based study finds that changing from MDI to DPI is linked to greater healthcare use, though the veteran ...

Shifting from a metered-dose inhaler to a dry-powder inhaler for chronic obstructive pulmonary disease (COPD) and asthma in one healthcare system formulary led to increased healthcare utilization ...

After the Veterans Health Administration tweaked its formulary on an asthma and chronic obstructive pulmonary disease therapy, hospitalizations and emergency department visits increased, according to ...

Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive ...

Substantial challenges characterise the management of chronic obstructive pulmonary disease (COPD), including a progressively ...